CHMP4A and prostate carcinoma: It has been reported that the level of CHMP4A was markedly increased in men with high GS prostate cancer, and in patients with advanced high-grade serious ovarian cancer (HGSOC), and thereby it could act as a potential biomarker for cancers (34, 35).